Regeneron Pharmaceuticals, Inc. (0R2M.L) LSE

723.30

-2.065(-0.28%)

Updated at December 04 06:44PM

Currency In USD

Valuation

Market Cap76.86B
Enterprise Value77.08B
P/E Ratio16.36
PEG Ratio4.04
Price/Sales Ratio5.24
Price/Book Ratio2.42
Enterprise/Revenue5.25
Enterprise/EBITDA13.1

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.32
Operating Margin0.26

Management Effectiveness

Return On Assets0.11
Return On Equity0.15

Income Statement

Revenue14.2B
Revenue/Share137.5
Gross Profit12.23B
EBITDA5.32B
Net Income4.41B
Diluted EPS38.34

Balance Sheet

Total Cash8.44B
Total Cash/Share81.49
Total Debt2.71B
Total Debt/Equity0.09
Current Ratio4.06
Book Value Per Share298.76

Price History

52-Week Change-3.89
52-Week High998.57
52-Week Low689
Moving Average 50 Days947.92
Moving Average 200 Days834.06

Statistics

Average Volume1,962
Shares Outstanding102.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.52
Trailing Annual Dividend Yield0.49
Payout Ratio0.06
Last Split FactorN/A
Last Split DateN/A